Reference | </br>1:Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells. Liu T, Fang Z, Wang G, Shi M, Wang X, Jiang K, Yang Z, Cao R, Tao H, Wang X, Zhou J.Oncol Lett. 2016 Jan;11(1):182-188. Epub 2015 Nov 2. PMID: 26870186 Free PMC Article</br>2:Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists. Yan L, Wang J, Pan M, Qiu Q, Huang W, Qian H.Chem Biol Drug Des. 2016 Feb;87(2):306-11. doi: 10.1111/cbdd.12661. Epub 2015 Oct 5. PMID: 26360809 </br>3:Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man: a vote for BCTC. Benko R, Illényi L, Kelemen D, Papp R, Papp A, Bartho L.Eur J Pharmacol. 2012 Jan 5;674(1):44-50. doi: 10.1016/j.ejphar.2011.10.021. Epub 2011 Oct 25. PMID: 22056835 </br>4:Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing-temperature water bath. Tékus V, Bölcskei K, Kis-Varga A, Dézsi L, Szentirmay E, Visegrády A, Horváth C, Szolcsányi J, Petho G.Eur J Pharmacol. 2010 Sep 1;641(2-3):135-41. doi: 10.1016/j.ejphar.2010.05.052. Epub 2010 Jun 8. PMID: 20534382 </br>5:N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. Valenzano KJ, Grant ER, Wu G, Hachicha M, Schmid L, Tafesse L, Sun Q, Rotshteyn Y, Francis J, Limberis J, Malik S, Whittemore ER, Hodges D.J Pharmacol Exp Ther. 2003 Jul;306(1):377-86. Epub 2003 Apr 29. PMID: 12721338 Free Article</br>6:N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain. Pomonis JD, Harrison JE, Mark L, Bristol DR, Valenzano KJ, Walker K.J Pharmacol Exp Ther. 2003 Jul;306(1):387-93. Epub 2003 Apr 29. PMID: 12721336 Free Article
|